Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of
Cisplatin in Human Lung Cancer Cells

J 2019

Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells

ROSLI, Nur Farhanah, Michaela FOJTŮ, Adrian C. FISHER and Martin PUMERA

Basic information

Original name

Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells

Authors

ROSLI, Nur Farhanah (702 Singapore), Michaela FOJTŮ (203 Czech Republic, belonging to the institution), Adrian C. FISHER (826 United Kingdom of Great Britain and Northern Ireland) and Martin PUMERA (203 Czech Republic, guarantor)

Edition

Langmuir, WASHINGTON, AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA, 2019, 0743-7463

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 3.557

RIV identification code

RIV/00216224:14110/19:00108123

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1021/acs.langmuir.8b03086

UT WoS

000469409800032

Keywords in English

TARGETED DELIVERY; CYTOTOXICITY; TOXICITY; NANOCARRIER; LABELS

Abstract

V originále

Graphene oxide (GO) has been widely explored by many in drug delivery strategies and toxicity assays. The toxicity of graphene oxide depends on the size of the sheets. Smaller sheets show lower toxicity, a quality which is essential for utilization in biomedical applications. However, despite vast research on GO, anticancer properties and drug carrier capabilities of graphene oxide nanoplatelets have yet to be fully explored. Herein, we have uniquely prepared graphene oxide nanoplatelets (GONPs) from well-defined stacked graphite nanofibers (SGNF) with a base of 50 x 50 nm(2) for toxicity and drug potentiation studies when coadministered with the chemotherapeutic drug cisplatin (CP) in human lung cancer cells, A549 cells. Results obtained from our studies have found that not only were GONPs able to act as drug carriers, but they can also significantly potentiate anticancer effect of CP in A549 cells.

Links

GA18-24089S, research and development project

Name: Kvantitativní fázová mikroskopie pro 3D kvalitativní charakterizaci nádorových buněk

Investor: Czech Science Foundation

Citovat

ROSLI, Nur Farhanah, Michaela FOJTŮ, Adrian C. FISHER and Martin PUMERA. Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells. Langmuir. WASHINGTON: AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA, 2019, vol. 35, No 8, p. 3176-3182. ISSN 0743-7463. Available from: https://dx.doi.org/10.1021/acs.langmuir.8b03086.

@article{1612196,
   author = {Rosli, Nur Farhanah and Fojtů, Michaela and Fisher, Adrian C. and Pumera, Martin},
   article_location = {WASHINGTON},
   article_number = {8},
   doi = {http://dx.doi.org/10.1021/acs.langmuir.8b03086},
   keywords = {TARGETED DELIVERY; CYTOTOXICITY; TOXICITY; NANOCARRIER; LABELS},
   language = {eng},
   issn = {0743-7463},
   journal = {Langmuir},
   title = {Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells},
   url = {http://dx.doi.org/10.1021/acs.langmuir.8b03086},
   volume = {35},
   year = {2019}
}

TY  - JOUR
ID  - 1612196
AU  - Rosli, Nur Farhanah - Fojtů, Michaela - Fisher, Adrian C. - Pumera, Martin
PY  - 2019
TI  - Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells
JF  - Langmuir
VL  - 35
IS  - 8
SP  - 3176-3182
EP  - 3176-3182
PB  - AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN  - 07437463
KW  - TARGETED DELIVERY
KW  - CYTOTOXICITY
KW  - TOXICITY
KW  - NANOCARRIER
KW  - LABELS
UR  - http://dx.doi.org/10.1021/acs.langmuir.8b03086
L2  - http://dx.doi.org/10.1021/acs.langmuir.8b03086
N2  - Graphene oxide (GO) has been widely explored by many in drug delivery strategies and toxicity assays. The toxicity of graphene oxide depends on the size of the sheets. Smaller sheets show lower toxicity, a quality which is essential for utilization in biomedical applications. However, despite vast research on GO, anticancer properties and drug carrier capabilities of graphene oxide nanoplatelets have yet to be fully explored. Herein, we have uniquely prepared graphene oxide nanoplatelets (GONPs) from well-defined stacked graphite nanofibers (SGNF) with a base of 50 x 50 nm(2) for toxicity and drug potentiation studies when coadministered with the chemotherapeutic drug cisplatin (CP) in human lung cancer cells, A549 cells. Results obtained from our studies have found that not only were GONPs able to act as drug carriers, but they can also significantly potentiate anticancer effect of CP in A549 cells.
ER  -

ROSLI, Nur Farhanah, Michaela FOJTŮ, Adrian C. FISHER and Martin PUMERA. Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells. \textit{Langmuir}. WASHINGTON: AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA, 2019, vol.~35, No~8, p.~3176-3182. ISSN~0743-7463. Available from: https://dx.doi.org/10.1021/acs.langmuir.8b03086.

Detailed Information on Publication Record